Genagon Therapeutics

Developing antibodies for the treatment of cancer and inflammatory diseases

placeSolna, Stockholm County, Sweden calendar_todayFounded 2015 groups10 employees language genagon.com

Innovation

17 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 296 times.

YearFilings
20151
20161
20173
20187
20196
20202
20212
20223
20233

Investor mix

4 investors on record; lead investors include Almi Invest, UU Invest.

Investor typeCountShare
Venture capital4100%
Coming soon